Business
European retailers urge EU to tackle high Visa, Mastercard fees

Mastercard, Enza partner to boost fintech connectivity across

  • 23rd June 2025
Army discovers stolen 1m litres crude oil in Rivers

Navy destroys 800 illegal refineries, recovers 171,000 stolen

  • 20th June 2025

Oil prices slip as US delays decision on

  • 20th June 2025

NIBSS unveils advanced digital platform to modernise, enhance

  • 18th June 2025

Contact Info

Some Populer Post

Lagos reduces truck parking fee on Lekki-Epe axis

News

FG commits ₦200bn to strengthen food production nationwide 

News
European retailers urge EU to tackle high Visa, Mastercard fees

Mastercard, Enza partner to boost fintech connectivity across Africa

Business
PoS transactions hit N223tn as Nigerians shift away from ATMs

PoS transactions hit N223tn as Nigerians shift away from

News
  • Home
  • GlaxoSmithKline

Tag: GlaxoSmithKline

News

GSK sues Moderna for patent infringement over mRNA technology

British drugmaker GlaxoSmithKline has filed a lawsuit against Moderna in U.S. federal court in Delaware, accusing its American competitor of infringing on GSK’s patent rights related to messenger RNA technology used in the COVID-19 vaccine Spikevax. The lawsuit claims that Moderna’s lipid nanoparticles, which transport mRNA into the human body, violate several GSK patents covering […]

News

GSK shares jump over 6% after $2.2bn cancer lawsuit settlement

Shares of pharmaceutical giant, GlaxoSmithKline surged more than 6% after the company announced a settlement of up to $2.2 billion (€2.01 billion) to resolve tens of thousands of lawsuits in the US related to its discontinued heartburn medication, Zantac. The drug has faced numerous allegations of causing cancer. The settlement addresses approximately 93% of the […]

NGX halts trading of delisted-GSK shares
Business

GSK shareholders express concern over N1.274bn unclaimed dividends

GlaxoSmithKline Consumer Nigeria Plc’s unclaimed dividend of N1.274 billion has alarmed shareholders following the company’s delisting from the Nigerian Exchange Limited and termination of operations in the country. According to The Punch, after more than 50 years of operation, GSK declared in August that it would cease operations in Nigeria and switch to a distributor-led […]

Equity market loses N92bn as stocks tumbles
Business

GSK, Dangote Sugar boosts stock market by 0.22%

The Nigerian Exchange Limited All-Share Index increased by 0.22 percent at the conclusion of the previous week due to gains in the stocks of Dangote Sugar Refinery Plc (25%) and Glaxo Smithkline Consumer Nigeria Plc (20.27%). The Punch reported that the market capitalization increased to N35.48 trillion from N35.4 trillion the previous week, giving investors a […]

NGX halts trading of delisted-GSK shares
Business

Shareholders demand payment as GSK quits

Following the reported closure of GlaxoSmithKline Consumer Nigeria Plc’s activities in the country, shareholders have requested adequate reimbursement for their investment. The Punch reported that in a statement released on Thursday and signed by the company secretary for GSK’s Nigerian subsidiary, Frederick Ichekwai, the company said it would cease operations in Nigeria and switch to a […]

Obi offers measures to prevent exit of multinational companies from Nigeria
Business

GSK: Nigeria’s poverty index getting worse, Peter Obi laments

The presidential candidate of the Labour Party in the 2023 election, Peter Obi, has expressed concern about GlaxoSmithKline’s impending departure from Nigeria after 51 years of operations. The Punch reported that this came after the business announced plans to stop producing vaccines and prescription drugs in the country. GlaxoSmithKline was incorporated in Nigeria in June 1971 and […]

Sign Up for Our Newsletter

Subscribe to our newsletter to get our newest articles instantly!

Email Us: [email protected]

ambusinessng @2025. All Rights Reserved.

Facebook-f Pinterest-p Youtube Instagram Linkedin-in